Companies /Healthcare

American Well Corporation - Class A

NYSE: AMWL Health Information Services
$11.03
▼ $0.17 (−1.52%) today
Markets closed · 10:17pm ET

AMWL at a Glance

Valuation
Market cap
$192.9M
Profitability
Revenue (TTM)
$211.2M
Profit margin
-27.0%
EPS (TTM)
$-3.43
Price
52-week range
$4 – $15
Street target
$13.60
Earnings
Next report
Feb 10, 2027

Headquartered in Boston, MA Fiscal year ends December NYSE: AMWL business.amwell.com

About American Well

American Well Corporation (Amwell) provides a SaaS-based, technology-enabled healthcare platform to payers (health plans), employers, health systems and government customers, including the U.S. Defense Health Agency. The Amwell Platform combines software and services that power digital clinical programs from Amwell and its partners, giving patients unified, personalized access to care across the continuum. Revenue comes mainly from two sources: platform subscription fees and visit fees from the Amwell Medical Group (AMG), its clinician network. The company also offers behavioral health programs through SilverCloud, along with Amwell Converge and Carepoint. It has divested non-core assets, including its APC business, and is pursuing a strategic transformation focused on a single platform, cost reduction, and positioning for AI-powered care delivery. Updated

AMWL Coverage

Frequently Asked Questions

What does American Well do?

American Well Corporation (Amwell) provides a SaaS-based, technology-enabled healthcare platform to payers (health plans), employers, health systems and government customers, including the U.S. Defense Health Agency.

What is the AMWL stock price target?

The Wall Street consensus 12-month price target for AMWL is $13.60.